Metabolomics and correlation network analysis of follicular fluid reveals associations between l‐tryptophan, l‐tyrosine and polycystic ovary syndrome

Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder in women of reproductive age. Some studies have investigated metabolic alterations in plasma and follicular fluid from PCOS patients, but they did not control for obesity or insulin resistance (IR); additionally, correlation ana...

Full description

Saved in:
Bibliographic Details
Published inBiomedical chromatography Vol. 35; no. 3; pp. e4993 - n/a
Main Authors Hou, Entai, Zhao, Yue, Hang, Jing, Qiao, Jie
Format Journal Article
LanguageEnglish
Published England 01.03.2021
Subjects
Online AccessGet full text
ISSN0269-3879
1099-0801
1099-0801
DOI10.1002/bmc.4993

Cover

Loading…
Abstract Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder in women of reproductive age. Some studies have investigated metabolic alterations in plasma and follicular fluid from PCOS patients, but they did not control for obesity or insulin resistance (IR); additionally, correlation analysis of metabolites is sparse. Accordingly, in this study, we aimed to examine metabolic differences owing to the pathogenesis of PCOS, identify the hub metabolites and investigate its associations with androgens. We applied GC–MS platform coupled with a correlation network approach to analyze follicular fluid samples from 32 PCOS patients without obesity and IR and 31 healthy women. Thirty significantly altered metabolites in PCOS patients were enriched in amino acid metabolism. l‐Phenylalanine, l‐tryptophan, pyroglutamic acid, l‐tyrosine, l‐leucine and l‐valine were screened as hub metabolites in metabolic correlation network. Among them, increased l‐tryptophan and l‐tyrosine were altered hub metabolites, and they had a more significant impact on the metabolic change of PCOS. In addition, l‐tryptophan and l‐tyrosine were significantly positively associated with serum androgens levels in the PCOS. Our results suggest that disorders of amino acid metabolism, especially tryptophan and tyrosine metabolism, might play an important role in the development of PCOS in predisposed women without obesity and IR.
AbstractList Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder in women of reproductive age. Some studies have investigated metabolic alterations in plasma and follicular fluid from PCOS patients, but they did not control for obesity or insulin resistance (IR); additionally, correlation analysis of metabolites is sparse. Accordingly, in this study, we aimed to examine metabolic differences owing to the pathogenesis of PCOS, identify the hub metabolites and investigate its associations with androgens. We applied GC-MS platform coupled with a correlation network approach to analyze follicular fluid samples from 32 PCOS patients without obesity and IR and 31 healthy women. Thirty significantly altered metabolites in PCOS patients were enriched in amino acid metabolism. l-Phenylalanine, l-tryptophan, pyroglutamic acid, l-tyrosine, l-leucine and l-valine were screened as hub metabolites in metabolic correlation network. Among them, increased l-tryptophan and l-tyrosine were altered hub metabolites, and they had a more significant impact on the metabolic change of PCOS. In addition, l-tryptophan and l-tyrosine were significantly positively associated with serum androgens levels in the PCOS. Our results suggest that disorders of amino acid metabolism, especially tryptophan and tyrosine metabolism, might play an important role in the development of PCOS in predisposed women without obesity and IR.Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder in women of reproductive age. Some studies have investigated metabolic alterations in plasma and follicular fluid from PCOS patients, but they did not control for obesity or insulin resistance (IR); additionally, correlation analysis of metabolites is sparse. Accordingly, in this study, we aimed to examine metabolic differences owing to the pathogenesis of PCOS, identify the hub metabolites and investigate its associations with androgens. We applied GC-MS platform coupled with a correlation network approach to analyze follicular fluid samples from 32 PCOS patients without obesity and IR and 31 healthy women. Thirty significantly altered metabolites in PCOS patients were enriched in amino acid metabolism. l-Phenylalanine, l-tryptophan, pyroglutamic acid, l-tyrosine, l-leucine and l-valine were screened as hub metabolites in metabolic correlation network. Among them, increased l-tryptophan and l-tyrosine were altered hub metabolites, and they had a more significant impact on the metabolic change of PCOS. In addition, l-tryptophan and l-tyrosine were significantly positively associated with serum androgens levels in the PCOS. Our results suggest that disorders of amino acid metabolism, especially tryptophan and tyrosine metabolism, might play an important role in the development of PCOS in predisposed women without obesity and IR.
Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder in women of reproductive age. Some studies have investigated metabolic alterations in plasma and follicular fluid from PCOS patients, but they did not control for obesity or insulin resistance (IR); additionally, correlation analysis of metabolites is sparse. Accordingly, in this study, we aimed to examine metabolic differences owing to the pathogenesis of PCOS, identify the hub metabolites and investigate its associations with androgens. We applied GC–MS platform coupled with a correlation network approach to analyze follicular fluid samples from 32 PCOS patients without obesity and IR and 31 healthy women. Thirty significantly altered metabolites in PCOS patients were enriched in amino acid metabolism. l‐Phenylalanine, l‐tryptophan, pyroglutamic acid, l‐tyrosine, l‐leucine and l‐valine were screened as hub metabolites in metabolic correlation network. Among them, increased l‐tryptophan and l‐tyrosine were altered hub metabolites, and they had a more significant impact on the metabolic change of PCOS. In addition, l‐tryptophan and l‐tyrosine were significantly positively associated with serum androgens levels in the PCOS. Our results suggest that disorders of amino acid metabolism, especially tryptophan and tyrosine metabolism, might play an important role in the development of PCOS in predisposed women without obesity and IR.
Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder in women of reproductive age. Some studies have investigated metabolic alterations in plasma and follicular fluid from PCOS patients, but they did not control for obesity or insulin resistance (IR); additionally, correlation analysis of metabolites is sparse. Accordingly, in this study, we aimed to examine metabolic differences owing to the pathogenesis of PCOS, identify the hub metabolites and investigate its associations with androgens. We applied GC–MS platform coupled with a correlation network approach to analyze follicular fluid samples from 32 PCOS patients without obesity and IR and 31 healthy women. Thirty significantly altered metabolites in PCOS patients were enriched in amino acid metabolism. l ‐Phenylalanine, l ‐tryptophan, pyroglutamic acid, l ‐tyrosine, l ‐leucine and l ‐valine were screened as hub metabolites in metabolic correlation network. Among them, increased l ‐tryptophan and l ‐tyrosine were altered hub metabolites, and they had a more significant impact on the metabolic change of PCOS. In addition, l ‐tryptophan and l ‐tyrosine were significantly positively associated with serum androgens levels in the PCOS. Our results suggest that disorders of amino acid metabolism, especially tryptophan and tyrosine metabolism, might play an important role in the development of PCOS in predisposed women without obesity and IR.
Author Qiao, Jie
Zhao, Yue
Hang, Jing
Hou, Entai
Author_xml – sequence: 1
  givenname: Entai
  orcidid: 0000-0002-0596-7195
  surname: Hou
  fullname: Hou, Entai
  organization: Key Laboratory of Assisted Reproduction (Peking University)
– sequence: 2
  givenname: Yue
  surname: Zhao
  fullname: Zhao, Yue
  organization: Key Laboratory of Assisted Reproduction (Peking University)
– sequence: 3
  givenname: Jing
  surname: Hang
  fullname: Hang, Jing
  email: hang1124jing@163.com
  organization: Key Laboratory of Assisted Reproduction (Peking University)
– sequence: 4
  givenname: Jie
  orcidid: 0000-0003-2126-1376
  surname: Qiao
  fullname: Qiao, Jie
  email: jie.qiao@263.net
  organization: Key Laboratory of Assisted Reproduction (Peking University)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32986877$$D View this record in MEDLINE/PubMed
BookMark eNp1kU1uFDEQhS2UiEwCEidAXrKgJ2W7f-wljPiTEmUT1pbb7RYGt93Y7kS9yxHYcj1OgjOTwAZWJZe-96pc7xQd-eANQi8IbAkAPe8nva2FYE_QhoAQFXAgR2gDtBUV4504QacpfQUA0dLuKTphVPCWd90G_bw0WfXBhcnqhJUfsA4xGqeyDR57k29D_Fb6yq3JJhxGPAbnrF6cinh0ix1wNDdGuSJOKWi7FybcF6UxHrtfdz9yXOcc5i_Kvz681xiS9WY_bg5u1WvKVuNwo-KK0-qHGCbzDB2PxdY8f6hn6PP7d9e7j9XF1YdPuzcXlWaUsKqreyM63uuaM2g4byihqtVAa-C17tqBad60NdHABOWatoWiIGBshAIGjJ2hVwffOYbvi0lZTjZp45zyJixJ0rruGGkIowV9-YAu_WQGOUc7lZXl4zkLsD0AuvwwRTNKbfP-Ijkq6yQBeZ-XLHnJ-7z-Dv8jePT8B1od0FvrzPpfTr693O3537nSqAI
CitedBy_id crossref_primary_10_1016_j_rbmo_2023_103762
crossref_primary_10_1055_s_0041_1729841
crossref_primary_10_3389_fendo_2024_1426517
crossref_primary_10_7759_cureus_71199
crossref_primary_10_1016_j_taap_2024_117187
crossref_primary_10_3390_metabo11090623
crossref_primary_10_1016_j_foodres_2024_114138
crossref_primary_10_1093_toxres_tfae169
crossref_primary_10_3390_biom14080918
crossref_primary_10_1016_j_jpba_2023_115602
crossref_primary_10_1080_10408363_2024_2430775
crossref_primary_10_1186_s12967_024_04952_y
crossref_primary_10_1016_j_mce_2024_112381
crossref_primary_10_3389_fendo_2024_1354214
crossref_primary_10_1177_11786469221099214
crossref_primary_10_1096_fj_202400453R
crossref_primary_10_1016_j_clnesp_2024_11_013
crossref_primary_10_1002_bmc_5500
crossref_primary_10_3390_ijms22168735
crossref_primary_10_3390_nu15194153
crossref_primary_10_1155_2022_6877541
crossref_primary_10_1007_s11694_023_02283_y
crossref_primary_10_3389_fcell_2021_777224
crossref_primary_10_3389_fendo_2021_747944
crossref_primary_10_1016_j_ab_2022_114665
crossref_primary_10_1007_s10815_022_02647_1
crossref_primary_10_3390_biomedicines10112852
crossref_primary_10_3390_ijms25094977
crossref_primary_10_1186_s12964_023_01410_y
crossref_primary_10_3390_separations9110329
crossref_primary_10_1007_s00210_023_02750_9
crossref_primary_10_3390_biomedicines10061254
crossref_primary_10_1016_j_microc_2023_108938
Cites_doi 10.1080/09513590.2019.1576616
10.1152/ajpendo.00401.2018
10.1373/clinchem.2011.176396
10.1016/j.cca.2019.11.016
10.1186/1471-2105-8-207
10.1038/nature11986
10.1021/ac402503m
10.1016/j.metabol.2015.01.008
10.1038/nrg2918
10.1111/cen.14056
10.1021/ac202828r
10.1109/TVCG.2015.2467771
10.1007/s00018-007-7053-7
10.1186/1741-7015-10-153
10.1016/j.mcna.2014.09.003
10.1186/1471-2393-14-11
10.1210/er.2015-1104
10.1353/pbm.1970.0001
10.1186/1752-0509-8-6
10.1038/s41573-019-0016-5
10.1016/j.metabol.2017.03.002
10.1016/j.fertnstert.2019.01.028
10.1055/s-0032-1328878
10.1186/s12863-015-0259-z
10.1016/j.fertnstert.2004.11.070
10.1016/j.aca.2014.11.009
10.1016/j.febslet.2009.03.001
10.1016/j.freeradbiomed.2015.05.013
10.1021/ac051495j
10.1210/jc.2012-1382
10.1038/nm.2307
10.1007/s10815-013-0004-3
10.1016/j.mce.2017.06.026
10.1186/1752-0509-5-1
10.1097/MD.0000000000004526
10.1186/cc3818
10.1002/bmc.4133
10.1038/ki.2010.333
10.1016/j.metabol.2018.11.002
10.1016/j.bbrc.2014.06.089
10.1210/jcem.87.2.8199
10.1016/j.jsbmb.2018.08.008
10.1186/1477-7827-9-7
10.1097/GRF.0b013e31802f54c8
10.1186/s12958-019-0490-y
10.1530/EJE-14-0253
10.1038/s41591-019-0509-0
10.1021/pr3000317
10.1016/j.fertnstert.2008.09.070
10.1093/humupd/dmq001
ContentType Journal Article
Copyright 2020 John Wiley & Sons, Ltd.
Copyright_xml – notice: 2020 John Wiley & Sons, Ltd.
DBID AAYXX
CITATION
NPM
7X8
DOI 10.1002/bmc.4993
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

PubMed
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Chemistry
EISSN 1099-0801
EndPage n/a
ExternalDocumentID 32986877
10_1002_bmc_4993
BMC4993
Genre article
Journal Article
GrantInformation_xml – fundername: National Natural Science Foundation of China
  funderid: 31800624; 82071658
– fundername: National Key Research and Development Program of China
  funderid: 2018YFC1004403; 2018YFC1003702
– fundername: Beijing Nova Program
  funderid: Z201100006820010
– fundername: Key Clinical Program of Peking University Third Hospital
  funderid: BYSY2017031
– fundername: Beijing Nova Program
  grantid: Z201100006820010
– fundername: National Natural Science Foundation of China
  grantid: 82071658
– fundername: National Key Research and Development Program of China
  grantid: 2018YFC1003702
– fundername: Key Clinical Program of Peking University Third Hospital
  grantid: BYSY2017031
– fundername: National Key Research and Development Program of China
  grantid: 2018YFC1004403
– fundername: National Natural Science Foundation of China
  grantid: 31800624
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
23N
31~
33P
3SF
3WU
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AAHQN
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACPOU
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
AQPKS
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HF~
HGLYW
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LH5
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
P2P
P2W
P2X
P4D
PALCI
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
RNS
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
UB1
V2E
W8V
W99
WBFHL
WBKPD
WIB
WIH
WIK
WJL
WOHZO
WQJ
WRC
WRJ
WXSBR
WYISQ
XG1
XPP
XV2
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
NPM
7X8
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
ID FETCH-LOGICAL-c3213-74be978bc48305885212a6c024084c76d3c85641c03928c263052090f59a03033
IEDL.DBID DR2
ISSN 0269-3879
1099-0801
IngestDate Fri Jul 11 08:58:37 EDT 2025
Wed Feb 19 02:28:52 EST 2025
Tue Jul 01 03:41:57 EDT 2025
Thu Apr 24 23:03:09 EDT 2025
Wed Jan 22 16:31:14 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords l-tyrosine
PCOS
network analysis
l-tryptophan
amino acid metabolism
Language English
License 2020 John Wiley & Sons, Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3213-74be978bc48305885212a6c024084c76d3c85641c03928c263052090f59a03033
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-0596-7195
0000-0003-2126-1376
PMID 32986877
PQID 2447315132
PQPubID 23479
PageCount 14
ParticipantIDs proquest_miscellaneous_2447315132
pubmed_primary_32986877
crossref_citationtrail_10_1002_bmc_4993
crossref_primary_10_1002_bmc_4993
wiley_primary_10_1002_bmc_4993_BMC4993
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate March 2021
2021-03-00
2021-Mar
20210301
PublicationDateYYYYMMDD 2021-03-01
PublicationDate_xml – month: 03
  year: 2021
  text: March 2021
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Biomedical chromatography
PublicationTitleAlternate Biomed Chromatogr
PublicationYear 2021
References 2019; 91
2010; 16
2019; 92
2006; 78
2015; 854C
2019; 17
2019; 18
2011; 12
2014; 171
2012; 58
2011; 17
2016; 37
2012; 11
2014; 450
2012; 10
2012; 97
2017; 71
2009; 91
2015; 86
2002; 87
2019; 25
2007; 8
2014; 14
2019; 316
2007; 64
2014; 8
2018; 32
2019; 111
2010; 78
2015; 16
2019; 35
2018; 465
2015; 11
2015; 99
2013; 85
2016; 95
2007; 50
2019; 502
2005; 83
2019; 185
2011; 5
1970; 14
2012; 30
2011; 9
2015; 64
2005; 9
2013; 30
2009; 583
2013; 496
2016; 22
2012; 84
e_1_2_10_23_1
e_1_2_10_46_1
e_1_2_10_21_1
e_1_2_10_44_1
e_1_2_10_42_1
e_1_2_10_40_1
e_1_2_10_2_1
e_1_2_10_4_1
e_1_2_10_18_1
e_1_2_10_6_1
e_1_2_10_16_1
e_1_2_10_39_1
e_1_2_10_8_1
e_1_2_10_14_1
e_1_2_10_37_1
e_1_2_10_13_1
e_1_2_10_34_1
e_1_2_10_11_1
e_1_2_10_32_1
e_1_2_10_30_1
e_1_2_10_51_1
e_1_2_10_29_1
e_1_2_10_27_1
e_1_2_10_25_1
e_1_2_10_48_1
e_1_2_10_24_1
e_1_2_10_45_1
Kanazawa M. (e_1_2_10_20_1) 2015; 11
e_1_2_10_22_1
e_1_2_10_43_1
e_1_2_10_41_1
e_1_2_10_52_1
e_1_2_10_3_1
e_1_2_10_19_1
e_1_2_10_5_1
e_1_2_10_17_1
e_1_2_10_38_1
e_1_2_10_7_1
e_1_2_10_15_1
e_1_2_10_36_1
e_1_2_10_12_1
e_1_2_10_35_1
e_1_2_10_9_1
e_1_2_10_10_1
e_1_2_10_33_1
e_1_2_10_31_1
e_1_2_10_50_1
e_1_2_10_28_1
e_1_2_10_49_1
e_1_2_10_26_1
e_1_2_10_47_1
References_xml – volume: 5
  start-page: 1
  issue: 1
  year: 2011
  end-page: 12
  article-title: Metabolomic correlation‐network modules in based on a graph‐clustering approach
  publication-title: BMC Systems Biology
– volume: 450
  start-page: 863
  issue: 1
  year: 2014
  end-page: 869
  article-title: Analysis of metabolites in plasma reveals distinct metabolic features between Dahl salt‐sensitive rats and consomic SS.13(BN) rats
  publication-title: Biochemical and Biophysical Research Communications
– volume: 502
  start-page: 280
  year: 2019
  end-page: 286
  article-title: Metabolic alterations associated with polycystic ovary syndrome: A UPLC Q‐exactive based metabolomic study
  publication-title: Clinica Chimica Acta
– volume: 87
  start-page: 742
  issue: 2
  year: 2002
  end-page: 746
  article-title: Altered vascular function in young women with polycystic ovary syndrome
  publication-title: The Journal of Clinical Endocrinology & Metabolism
– volume: 12
  start-page: 56
  issue: 1
  year: 2011
  end-page: 68
  article-title: Network medicine: A network‐based approach to human disease
  publication-title: Nature Reviews Genetics
– volume: 97
  start-page: 3,709
  issue: 10
  year: 2012
  end-page: 3,716
  article-title: Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance
  publication-title: The Journal of Clinical Endocrinology & Metabolism
– volume: 14
  start-page: 154
  issue: 1
  year: 1970
  end-page: 170
  article-title: The history of the tricarboxylic acid cycle
  publication-title: Perspectives in Biology and Medicine
– volume: 95
  issue: 36
  year: 2016
  article-title: Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: A meta‐analysis
  publication-title: Medicine (Baltimore)
– volume: 18
  start-page: 379
  year: 2019
  end-page: 401
  article-title: Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
  publication-title: Nature Reviews Drug Discovery
– volume: 58
  start-page: 999
  issue: 6
  year: 2012
  end-page: 1009
  article-title: Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: Plasma metabolomic approach using GC–MS
  publication-title: Clinical Chemistry
– volume: 465
  start-page: 36
  year: 2018
  end-page: 47
  article-title: Role of androgens in the ovary
  publication-title: Molecular and Cellular Endocrinology
– volume: 9
  start-page: 7
  year: 2011
  article-title: Is interleukin‐18 associated with polycystic ovary syndrome?
  publication-title: Reproductive Biology and Endocrinology
– volume: 316
  start-page: E383
  issue: 3
  year: 2019
  end-page: e396
  article-title: Obesity leads to distinct metabolomic signatures in follicular fluid of women undergoing in vitro fertilization
  publication-title: American Journal of Physiology. Endocrinology and Metabolism
– volume: 11
  start-page: S732
  issue: s8
  year: 2015
  end-page: S737
  article-title: Criteria and classification of obesity in Japan and Asia–Oceania
  publication-title: Asia Pacific Journal of Clinical Nutrition
– volume: 11
  start-page: 2,937
  issue: 5
  year: 2012
  end-page: 2,946
  article-title: Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients
  publication-title: Journal of Proteome Research
– volume: 64
  start-page: 720
  issue: 6
  year: 2015
  end-page: 728
  article-title: Effect of insulin sensitizer therapy on amino acids and their metabolites
  publication-title: Metabolism
– volume: 35
  start-page: 463
  issue: 6
  year: 2019
  end-page: 469
  article-title: Potential roles of carnitine in patients with polycystic ovary syndrome: A systematic review
  publication-title: Gynecological Endocrinology
– volume: 17
  start-page: 448
  issue: 4
  year: 2011
  end-page: 453
  article-title: Metabolite profiles and the risk of developing diabetes
  publication-title: Nature Medicine
– volume: 78
  start-page: 567
  issue: 78
  year: 2006
  end-page: 574
  article-title: Large‐scale human metabolomics studies: A strategy for data (pre‐) processing and validation
  publication-title: Analytical Chemistry
– volume: 496
  start-page: 238
  issue: 7444
  year: 2013
  end-page: 242
  article-title: Succinate is an inflammatory signal that induces IL‐1β through HIF‐1
  publication-title: Nature
– volume: 16
  start-page: 347
  issue: 4
  year: 2010
  end-page: 363
  article-title: Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: A systematic review and meta‐analysis
  publication-title: Human Reproduction Update
– volume: 9
  start-page: 588
  issue: 6
  year: 2005
  end-page: 593
  article-title: Lactate as a marker of energy failure in critically ill patients: Hypothesis
  publication-title: Critical Care
– volume: 32
  issue: 4
  year: 2018
  article-title: Combined metabolomic and correlation networks analyses reveal fumarase insufficiency altered amino acids metabolism
  publication-title: Biomedical Chromatography
– volume: 86
  start-page: 295
  year: 2015
  end-page: 307
  article-title: Metabolism alteration in follicular niche: The nexus among intermediary metabolism, mitochondrial function, and classic polycystic ovary syndrome
  publication-title: Free Radical Biology & Medicine
– volume: 92
  start-page: 108
  year: 2019
  end-page: 120
  article-title: Characteristics of obesity in polycystic ovary syndrome: Etiology, treatment, and genetics
  publication-title: Metabolism
– volume: 50
  start-page: 277
  issue: 1
  year: 2007
  end-page: 294
  article-title: Obesity and lifestyle management in polycystic ovary syndrome
  publication-title: Clinical Obstetrics and Gynecology
– volume: 25
  start-page: 1,225
  issue: 8
  year: 2019
  end-page: 1,233
  article-title: Gut microbiota–bile acid–interleukin‐22 axis orchestrates polycystic ovary syndrome
  publication-title: Nature Medicine
– volume: 583
  start-page: 1759
  year: 2009
  end-page: 1765
  article-title: A network base approach to human disease
  publication-title: FEBS Letters
– volume: 84
  start-page: 428
  issue: 1
  year: 2012
  end-page: 439
  article-title: Pattern recognition approaches and computational systems tools for ultra performance liquid chromatography–mass spectrometry‐based comprehensive metabolomic profiling and pathways analysis of biological data sets
  publication-title: Analytical Chemistry
– volume: 71
  start-page: 52
  year: 2017
  end-page: 63
  article-title: Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome
  publication-title: Metabolism
– volume: 78
  start-page: 1,214
  issue: 12
  year: 2010
  end-page: 1,217
  article-title: High glucose and renin release: The role of succinate and GPR91
  publication-title: Kidney International
– volume: 37
  start-page: 467
  issue: 5
  year: 2016
  end-page: 520
  article-title: The pathogenesis of polycystic ovary syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited
  publication-title: Endocrine Reviews
– volume: 14
  issue: 1
  year: 2014
  article-title: Metabolic heterogeneity of follicular amino acids in polycystic ovary syndrome is affected by obesity and related to pregnancy outcome
  publication-title: Bmc Pregnancy & Childbirth
– volume: 83
  start-page: 1,454
  issue: 5
  year: 2005
  end-page: 1,460
  article-title: Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment
  publication-title: Fertility & Sterility
– volume: 10
  issue: 1
  year: 2012
  article-title: Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: Plasma metabolomics analysis
  publication-title: BMC Medicine
– volume: 17
  issue: 1
  year: 2019
  article-title: Identification of potential metabolic biomarkers of polycystic ovary syndrome in follicular fluid by SWATH mass spectrometry
  publication-title: Reproductive Biology and Endocrinology
– volume: 111
  start-page: 471
  issue: 3
  year: 2019
  end-page: 472
  article-title: Polycystic ovary syndrome: A reproductive and metabolic web of risk, comorbidities, and disease
  publication-title: Fertility and Sterility
– volume: 22
  start-page: 160
  issue: 1
  year: 2016
  end-page: 169
  article-title: TrajGraph: A graph‐based visual analytics approach to studying urban network centralities using taxi trajectory data
  publication-title: IEEE Transactions on Visualization and Computer Graphics
– volume: 8
  start-page: 6
  year: 2014
  article-title: Protein interaction networks as metric spaces: A novel perspective on distribution of hubs
  publication-title: BMC Systems Biology
– volume: 91
  start-page: 1,563
  issue: 4 Suppl
  year: 2009
  end-page: 1,567
  article-title: Long‐term consequences of polycystic ovary syndrome on cardiovascular risk
  publication-title: Fertility and Sterility
– volume: 85
  start-page: 11,725
  issue: 24
  year: 2013
  end-page: 11,731
  article-title: Metabolite profiling of a NIST standard reference material for human plasma (SRM 1950): GC–MS, LC–MS, NMR, and clinical laboratory analyses, libraries, and web‐based resources
  publication-title: Analytical Chemistry
– volume: 91
  start-page: 508
  issue: 4
  year: 2019
  end-page: 516
  article-title: Changes in whole metabolites after exenatide treatment in overweight/obese polycystic ovary syndrome patients
  publication-title: Clinical Endocrinology
– volume: 171
  start-page: 1
  issue: 4
  year: 2014
  end-page: 29
  article-title: The polycystic ovary syndrome: An endocrinological perspective from the European Society of Endocrinology
  publication-title: European Journal of Endocrinology
– volume: 16
  year: 2015
  article-title: Importance of presenting the variability of the false discovery rate control
  publication-title: BMC Genetics
– volume: 185
  start-page: 142
  year: 2019
  end-page: 149
  article-title: Follicular dynamics of glycerophospholipid and sphingolipid metabolisms in polycystic ovary syndrome patients
  publication-title: The Journal of Steroid Biochemistry and Molecular Biology
– volume: 854C
  start-page: 95
  year: 2015
  end-page: 105
  article-title: Reconstruction and analysis of correlation networks based on GC–MS metabolomics data for young hypertensive men
  publication-title: Analytica Chimica Acta
– volume: 64
  start-page: 1739
  issue: 14
  year: 2007
  end-page: 1751
  article-title: Network analysis approach for biology
  publication-title: Cellular and Molecular Life Sciences
– volume: 30
  start-page: 1,231
  issue: 9
  year: 2013
  end-page: 1,238
  article-title: A proteomic analysis of human follicular fluid: Comparison between fertilized oocytes and non‐fertilized oocytes in the same patient
  publication-title: Journal of Assisted Reproduction and Genetics
– volume: 8
  start-page: 207
  issue: 1
  year: 2007
  article-title: Orthogonal projections to latent structures as a strategy for microarray data normalization
  publication-title: BMC Bioinformatics
– volume: 30
  start-page: 496
  issue: 6
  year: 2012
  end-page: 506
  article-title: Obesity and PCOS: Implications for diagnosis and treatment
  publication-title: Seminars in Reproductive Medicine
– volume: 99
  start-page: 221
  issue: 1
  year: 2015
  end-page: 235
  article-title: Polycystic ovarian syndrome
  publication-title: The Medical Clinics of North America
– ident: e_1_2_10_27_1
  doi: 10.1080/09513590.2019.1576616
– ident: e_1_2_10_34_1
  doi: 10.1152/ajpendo.00401.2018
– ident: e_1_2_10_11_1
  doi: 10.1373/clinchem.2011.176396
– ident: e_1_2_10_8_1
  doi: 10.1016/j.cca.2019.11.016
– ident: e_1_2_10_6_1
  doi: 10.1186/1471-2105-8-207
– ident: e_1_2_10_39_1
  doi: 10.1038/nature11986
– ident: e_1_2_10_35_1
  doi: 10.1021/ac402503m
– ident: e_1_2_10_18_1
  doi: 10.1016/j.metabol.2015.01.008
– ident: e_1_2_10_2_1
  doi: 10.1038/nrg2918
– ident: e_1_2_10_38_1
  doi: 10.1111/cen.14056
– ident: e_1_2_10_46_1
  doi: 10.1021/ac202828r
– ident: e_1_2_10_17_1
  doi: 10.1109/TVCG.2015.2467771
– ident: e_1_2_10_23_1
  doi: 10.1007/s00018-007-7053-7
– ident: e_1_2_10_52_1
  doi: 10.1186/1741-7015-10-153
– ident: e_1_2_10_40_1
  doi: 10.1016/j.mcna.2014.09.003
– ident: e_1_2_10_50_1
  doi: 10.1186/1471-2393-14-11
– ident: e_1_2_10_33_1
  doi: 10.1210/er.2015-1104
– ident: e_1_2_10_22_1
  doi: 10.1353/pbm.1970.0001
– ident: e_1_2_10_12_1
  doi: 10.1186/1752-0509-8-6
– ident: e_1_2_10_30_1
  doi: 10.1038/s41573-019-0016-5
– ident: e_1_2_10_7_1
  doi: 10.1016/j.metabol.2017.03.002
– volume: 11
  start-page: S732
  issue: 8
  year: 2015
  ident: e_1_2_10_20_1
  article-title: Criteria and classification of obesity in Japan and Asia–Oceania
  publication-title: Asia Pacific Journal of Clinical Nutrition
– ident: e_1_2_10_3_1
  doi: 10.1016/j.fertnstert.2019.01.028
– ident: e_1_2_10_24_1
  doi: 10.1055/s-0032-1328878
– ident: e_1_2_10_25_1
  doi: 10.1186/s12863-015-0259-z
– ident: e_1_2_10_10_1
  doi: 10.1016/j.fertnstert.2004.11.070
– ident: e_1_2_10_43_1
  doi: 10.1016/j.aca.2014.11.009
– ident: e_1_2_10_48_1
  doi: 10.1016/j.febslet.2009.03.001
– ident: e_1_2_10_51_1
  doi: 10.1016/j.freeradbiomed.2015.05.013
– ident: e_1_2_10_5_1
  doi: 10.1021/ac051495j
– ident: e_1_2_10_19_1
  doi: 10.1210/jc.2012-1382
– ident: e_1_2_10_45_1
  doi: 10.1038/nm.2307
– ident: e_1_2_10_4_1
  doi: 10.1007/s10815-013-0004-3
– ident: e_1_2_10_42_1
  doi: 10.1016/j.mce.2017.06.026
– ident: e_1_2_10_13_1
  doi: 10.1186/1752-0509-5-1
– ident: e_1_2_10_49_1
  doi: 10.1097/MD.0000000000004526
– ident: e_1_2_10_41_1
  doi: 10.1186/cc3818
– ident: e_1_2_10_16_1
  doi: 10.1002/bmc.4133
– ident: e_1_2_10_29_1
  doi: 10.1038/ki.2010.333
– ident: e_1_2_10_14_1
  doi: 10.1016/j.metabol.2018.11.002
– ident: e_1_2_10_44_1
  doi: 10.1016/j.bbrc.2014.06.089
– ident: e_1_2_10_21_1
  doi: 10.1210/jcem.87.2.8199
– ident: e_1_2_10_26_1
  doi: 10.1016/j.jsbmb.2018.08.008
– ident: e_1_2_10_47_1
  doi: 10.1186/1477-7827-9-7
– ident: e_1_2_10_15_1
  doi: 10.1097/GRF.0b013e31802f54c8
– ident: e_1_2_10_37_1
  doi: 10.1186/s12958-019-0490-y
– ident: e_1_2_10_9_1
  doi: 10.1530/EJE-14-0253
– ident: e_1_2_10_31_1
  doi: 10.1038/s41591-019-0509-0
– ident: e_1_2_10_36_1
  doi: 10.1021/pr3000317
– ident: e_1_2_10_32_1
  doi: 10.1016/j.fertnstert.2008.09.070
– ident: e_1_2_10_28_1
  doi: 10.1093/humupd/dmq001
SSID ssj0009627
Score 2.427159
Snippet Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder in women of reproductive age. Some studies have investigated metabolic alterations in...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e4993
SubjectTerms amino acid metabolism
l‐tryptophan
l‐tyrosine
network analysis
PCOS
Title Metabolomics and correlation network analysis of follicular fluid reveals associations between l‐tryptophan, l‐tyrosine and polycystic ovary syndrome
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fbmc.4993
https://www.ncbi.nlm.nih.gov/pubmed/32986877
https://www.proquest.com/docview/2447315132
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3Pa9swFMcfo4dtl61L9yNtN1Qo7WVOE8uWpWMXVkohO4wWCjsYSZZhzLXDkhSy0_6EXffv7S_pe5Kd0HWFslNwkK04epK_kr_6PID9rCjLNLUuItxblBRKRcako8jJ1GoaFpWjBf3JJ3F6kZxdppetq5L2wgQ-xGrBjXqGH6-pg2szO1pDQ82VHaBcJ9AnWbVID31ek6Mop0xYXlGEj1Udd3YYH3Un3n4S3ZGXt9Wqf9ycPIcv3Q8NLpNvg8XcDOyPvxiO_3cnm_CsVaHsOITNC3jk6h5sHdc4A79asgPmfaF-wb0HT8ZdTrgePJ60r-K34PfEzTGAKtrVPGO6LpilRB_BWsfq4C7H7wPzhDUlK4n_7W2vrKwWXwtG9CiMfqbXITJjrXGMVX9-_sI6pwQ-0PX7cLzEfxJr99VNm2ppl4SZZs013jzr4Asv4eLk4_n4NGrzPESWxyMeZYlxOJk1NpE4-khJ24m1sJ6-lthMFNzKVCQjO0QxJ20suDfvDMtUaRyjOH8FG3VTuzfAMueM1EKJMsGJfxGrMsmMGJrUcu4KLvtw2LV5blsIOuXiqPKAb45zbIycGqMPe6uS0wD--FeZLmxybAh61aJr1yxmOYqmjKOY4nEfXod4Wl2Fx0oKmWV9OPBRce_l8w-TMX1uP7TgDjyNyXLjLXK7sDH_vnBvUTPNzTvfO24A6K0W5Q
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1Lb9NAEMdHpUiUC4-U0vBcJFQuOE289npXnEqgClD3gFqpByTLu15LCNeOmgQpnPgIXPl6fBJmdu1E5SEhTpGjtTfOzqxnx__9DcDTpCjLODY2INxbEBVKBVrHo8DK2OQ0LSpLCf30WExOo7dn8dkGvOj2wng-xCrhRp7h5mtycEpI76-pofrcDDBe51fgKhX0Jq989X7NjqKqMj7Bogggqzry7DDc7868_Cz6LcC8HK-6B87hTfjQ_VSvM_k0WMz1wHz5heL4n_dyC260gSg78JZzGzZs3YPtgxoX4edLtsecNNTl3HuwNe7KwvXgWtq-jd-G76mdow1VtLF5xvK6YIZqfXh1Hau9wBy_99gT1pSsJAS4U76yslp8LBgBpNABWL62khlrtWOs-vH1G_Y5JfZBXj_3x0v8K7F31920qZZmSaRp1nzGu2cdf-EOnB6-PhlPgrbUQ2B4OOJBEmmL61ltIokTkJS0ozgXxgHYIpOIghsZi2hkhhjPSRMK7vQ7wzJWOU5TnO_AZt3UdhdYYq2WuVCijHDtX4SqjBIthjo2nNuCyz486wY9My0HncpxVJknOIcZDkZGg9GHJ6uWU8_--FObzm4yHAh625LXtlnMMoybEo7xFA_7cNcb1OoqPFRSyCTpw54zi79ePnuZjunz3r82fAxbk5P0KDt6c_zuPlwPSYHjFHMPYHN-sbAPMYSa60fOVX4CK5wa_g
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1bb9MwFMePYEiDFwYdgzIuRkLjhXRpnDjO4-ioxqUTQkyaxEMUO7aEyJKKtkjliY_A677ePgnn2EmrcZEQT1Eix07iY_vY-ft3AJ6mpbVJok1AuLcgLrMsUCoZBkYmuqBuMTO0oD85Fkcn8evT5LRVVdJeGM-HWC24Uctw_TU18Glp99fQUHWmB-iu86twLRahpInX4fs1OoqCyvj1lYz4sVkHng2j_e7Oy0PRb_7lZXfVjTfjLfjYPamXmXweLOZqoL_9AnH8v1e5BTdbN5QdeLu5DVdM3YPtgxqn4GdLtsecMNStuPfg-qgLCteDzUn7L34bzidmjhZU0bbmGSvqkmmK9OG1daz28nK87qEnrLHMEgDc6V6ZrRafSkb4KDR_VqxtZMZa5RirLr7_wDKnRD4o6uf-fIlfEkt3xU2baqmXxJlmzVd8edbRF-7Ayfjlh9FR0AZ6CDSPhjxIY2VwNqt0LLH7kZL2ExdCO_xarFNRci0TEQ91iN6c1JHgTr0T2iQrsJPifAc26qY294ClxihZiEzYGGf-ZZTZOFUiVInm3JRc9uFZV-e5binoFIyjyj2_OcqxMnKqjD48WaWcevLHn9J0ZpNjRdC_lqI2zWKWo9eUcvSmeNSHu96eVrnwKJNCpmkf9pxV_DX7_MVkRMf7_5rwMWy-Oxznb18dv9mFGxHJb5xc7gFszL8szEP0n-bqkWsoPwHygRm2
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Metabolomics+and+correlation+network+analysis+of+follicular+fluid+reveals+associations+between+l-tryptophan%2C+l-tyrosine+and+polycystic+ovary+syndrome&rft.jtitle=Biomedical+chromatography&rft.au=Hou%2C+Entai&rft.au=Zhao%2C+Yue&rft.au=Hang%2C+Jing&rft.au=Qiao%2C+Jie&rft.date=2021-03-01&rft.issn=1099-0801&rft.eissn=1099-0801&rft.volume=35&rft.issue=3&rft.spage=e4993&rft_id=info:doi/10.1002%2Fbmc.4993&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0269-3879&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0269-3879&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0269-3879&client=summon